We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$470B
AUM Growth
+$74.8B
Cap. Flow
+$24.4B
Cap. Flow %
5.19%
Top 10 Hldgs %
30.35%
Holding
14,310
New
2,075
Increased
5,756
Reduced
4,471
Closed
1,856

Sector Composition

Rank Sector Weight
1 Technology 2.31%
2 Consumer Discretionary 1.61%
3 Financials 1.35%
4 Healthcare 1.15%
5 Communication Services 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENVB icon
11976
Enveric Biosciences
ENVB
$6.53M
$21K ﹤0.01%
+69
New +$29K
PRDS
11977
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$20.9K ﹤0.01%
+15,846
New +$25.9K
AQB icon
11978
CALL
AquaBounty Technologies
AQB
$6.85M
$20.8K ﹤0.01%
1,765
-880
-33% -$14.2K
LITB
11979
LightInTheBox
LITB
$60.8M
$20.8K ﹤0.01%
+2,154
New +$16.4K
SND icon
11980
CALL
Smart Sand
SND
$199M
$20.8K ﹤0.01%
+11,800
New +$21.9K
TRAW icon
11981
Traws Pharma
TRAW
$8.9M
$20.7K ﹤0.01%
+1,136
New +$24.6K
CPIX icon
11982
Cumberland Pharmaceuticals
CPIX
$130M
$20.7K ﹤0.01%
+10,633
New +$25.3K
CNTB
11983
Connect Biopharma Holdings
CNTB
$154M
$20.7K ﹤0.01%
20,670
-265
-1% -$289
JSPR icon
11984
PUT
Jasper Therapeutics
JSPR
$24M
$20.5K ﹤0.01%
+1,130
New +$20.9K
VISL
11985
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$20.4K ﹤0.01%
2,920
-1,280
-30% -$13K
ATER icon
11986
PUT
Aterian
ATER
$7.55M
$20.4K ﹤0.01%
1,975
+217
+12% +$2.9K
INM icon
11987
InMed Pharmaceuticals
INM
$7.69M
$20.3K ﹤0.01%
+941
New +$30.4K
SER icon
11988
Serina Therapeutics
SER
$68.6M
$20.3K ﹤0.01%
870
-619
-42% -$14.2K
BEST
11989
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$20.2K ﹤0.01%
6,404
-3,374
-35% -$9.93K
BACK
11990
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$20.1K ﹤0.01%
4,683
+2,619
+127% +$19K
VXRT
11991
PUT
DELISTED
Vaxart
VXRT
$20.1K ﹤0.01%
26,400
+600
+2% +$557
EQS icon
11992
Equus Total Return
EQS
$14.5M
$20K ﹤0.01%
12,792
-2,231
-15% -$3.59K
HRTX icon
11993
PUT
Heron Therapeutics
HRTX
$61.3M
$19.9K ﹤0.01%
13,200
-25,500
-66% -$63.9K
AMRX icon
11994
PUT
Amneal Pharmaceuticals
AMRX
$6.24B
$19.9K ﹤0.01%
14,300
-7,100
-33% -$14.1K
SUNW
11995
CALL
DELISTED
Sunworks, Inc.
SUNW
$19.9K ﹤0.01%
13,800
-19,000
-58% -$35.8K
DHC
11996
CALL
Diversified Healthcare Trust
DHC
$1.96B
$19.7K ﹤0.01%
+14,600
New +$15.1K
OUST icon
11997
PUT
Ouster
OUST
$2.61B
$19.7K ﹤0.01%
2,340
+620
+36% +$7.19K
BBGI icon
11998
Beasley Broadcasting Group
BBGI
$38M
$19.6K ﹤0.01%
+1,191
New +$25.2K
CYCN icon
11999
Cyclerion Therapeutics
CYCN
$18.7M
$19.6K ﹤0.01%
2,259
+1,306
+137% +$16.5K
SPIR icon
12000
CALL
Spire Global
SPIR
$558M
$19.6K ﹤0.01%
3,650
-6,138
-63% -$49K

Similar funds

Jeff Yass's Q1 2023 Portfolio in Review

As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $24.4B of net new capital in Q1 2023, opening 2,075 new positions and adding to 5,756 existing holdings. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Tesla, an estimated $1.62B trimmed.

  • Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
  • Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
  • Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
  • Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
  • Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.